New weight loss shot CPX101 enters early human testing
NCT ID NCT06545162
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tested a new injectable drug called CPX101 in 72 healthy volunteers and overweight or obese patients. The main goal was to check safety and how the body processes the drug, with a preliminary look at weight loss. The study is complete, but results are not yet available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CPX101 (a biologic drug given by injection)
What this could lead to
If it works, this could lead to a new injectable medication for weight loss in people who are overweight or obese.
What could go wrong
This is a very early Phase 1 trial focused on safety, not effectiveness. The drug may not cause significant weight loss or could have side effects. Results may not apply to the general population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Friendship Hospital
Beijing, Beijing Municipality, 100000, China
-
Beijing Luhe hospital
Beijing, Beijing Municipality, 100000, China
-
Beijing hospital
Beijing, Beijing Municipality, 100000, China